Active Ingredient History

  • Now
Dronabinol also known as (−)-trans-delta9-tetrahydrocannabinol is an active ingredient of cannabis. The drug was approved by FDA for the treatment of anorexia in patients with AIDS and chemotherapy-induced nausea and vomiting. Dronabinol exerts its action by activating CB1 and CB2 recepors which makes it a CNS active medicine.   NCATS

  • SMILES: CCCCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
  • Mol. Mass: 314.4617
  • ALogP: 5.74
  • ChEMBL Molecule:
More Chemistry
  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.5832 - $30.9842
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1-trans-delta-9-tetrahydrocannabinol | 3-pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6h-dibenzo(b,d)pyran-1-ol | 6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6h-benzo[c]chromen-1-ol | delta(1)-tetrahydrocannabinol | delta 9 tetrahydrocannabinol | delta-9 tetrahydrocannabinol | delta-9-tetrahydrocannabinol | delta9-tetrahydrocannabinol | delta-9-thc | delta(9)-thc | (-)-delta9-trans-tetrahydrocannabinol | dronabinol | dronabinolum | marinol | tetrahydrocannabinol | δ9-tetrahydrocannabinol


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue